Johnson & Johnson (JNJ)
Health care products behemoth Johnson & Johnson (JNJ) is the kind of profit machine every company wished it could be. The company delivered on the earnings front yet again with Tuesday’s stellar quarter that showed revenue rolling in at $18.4 billion — a 6.3% year-over-year increase.
Excluding special items, JNJ earned $3.6 billion, or $1.24 per share, a marked increase from the $3.4 billion, or $1.19 per share, in Q4, 2013. Both top- and bottom-line metrics beat Wall Street expectations.
For JNJ stock, it’s another quarter of outstanding performance, and for investors who like to set and forget their dividend stocks, JNJ stock is about as good as it gets. The company’s annual dividend yield of 2.8%, along with its 12-month price gain of nearly 30%, make JNJ stock a must-own, set-and-forget dividend stock.